Health Condition 1: I499- Cardiac arrhythmia, unspecified
Conditions
Interventions
Intervention1: Individualised homoeopathic medicine: Individualized homoeopathic medicines will be prescribed based on detailed case-taking, totality of symptoms, repertorization, and clinical judgeme
Sponsors
National Institute of Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age Group: Women aged 40 to 50 years. 2.Perimenopausal (irregular cycles and menopausal symptoms). 3.Postmenopausal (more than or equal to 12 months of amenorrhea). 4.Presence of Cardiac Arrhythmias Already diagnosed case of arrhythmias (e.g. palpitations, tachycardia, PVCs). Confirmed by ECG or clinical examination. 5.Patients who can read & understand either English, Hindi or Bengali if they are not able to read, the physician can help in filling 7.Consent for Willingness to participate and provide written informed consent.
Exclusion criteria
Exclusion criteria: 1.Women with pre-existing cardiac disease: Structural heart defects ,Ischemic heart disease, 2.Congenital heart disorders. 3.Use of Hormone Replacement Therapy (HRT) or Anti-arrhythmic drugs. 4.Patients who are on any recreational drugs 5.Patients who are already taking any homoeopathic treatment or other medications for any other chronic disease 6.Patient unwilling to take part, too sick for consultation, not giving consent to join the study 7.Patients who have had surgery in the past six weeks 8.Patients who are already on any treatment for cardiac arrhythmias 9.Patients who are suffering from some immune compromised illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in arrhythmia-related symptom burden, measured using the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) Part II (Symptom Burden Scale). The ASTA symptom scale consists of 9 items, each scored on a 4-point Likert scale (0 3). The total score will be summarized and transformed to a 0 100 scale, where higher scores indicate greater symptom burden. Assessment will be done at baseline and at post-intervention follow-up, and the mean change in the 0 100 transformed score will be used to determine improvement in symptom burden.Timepoint: at baseline and after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The Menopause Rating Scale (MRS) assesses menopausal symptoms using a 5-point Likert scale (0-4) for each of 11 items, categorized into somatic, psychological, and urogenital domains. Scores range from 0 to 44, with 0-4 indicating no/little complaints, 5-8 mild, 9-15 moderate, and 16+ severe. Scores are summed within each domain and then across all domains to get a total MRS score.Timepoint: at base line and after 6 months | — |
Countries
India
Contacts
Public ContactDr Syed Afsar Ali
National Institute of Homoeopathy
Outcome results
None listed